Zhejiang Nhu Co Ltd

Zhejiang Nhu Co Ltd

002001 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

25.28CNY-0.22 (-0.86%)

Price History

Full chart

Market Stats

Previous Close25.50
Open25.42
Day Range25.22 – 25.55
52-Week Range22.35 – 39.14
Volume11.84M
Market Cap79.76B
P/E (TTM)11.09
Forward P/E11.32
EPS2.34
Dividend Yield3.85%
Beta0.25
50-Day Avg28.10
200-Day Avg30.21

About

Zhejiang NHU Company Ltd., together with its subsidiaries, produces and sells nutritional products, fragrances and flavors, polymer materials, and active pharmaceutical ingredients in China and internationally. It operates through Pharmaceutical and Chemical; and Other segments. The company offers animal nutrition products comprising vitamins, amino acids, and carotenoids for poultry, swine, ruminants, and farmed fish; human nutrition products consisting of vitamins A, D3, E, H, C, B5, B6, and B12, as well as coenzyme Q10, beta carotene, taurine, and l-serine for use in nutritional supplements, food and beverages, and personal care applications; and flavor and fragrance products, including fruity, floral, and green/herbal products for use in soap, toothpaste, shampoo, skin care products, and food and beverage products. It also provides pigments; methionine, biotin, cysteine, and tryptophan; linalool, citral, leaf alcohol, methyl dihydrojasmonate, raspberry ketone, privet aldehyde, and menthol; PPS and PPA resins, PPS fibers, LTF composite materials, and PPS cast films and heat pipes; chemical products, such as prenol, l-ascorbic acid, acrylic acid, acrolein, sodium thiomethoxide in H2O, acrolein cyanohydrin acetate, diethyl oxalate/oxalic acid diethyl ester, potassium sulfate, ammonium sulfate, isophorone, cyclopentanone, and isovaleraldehyde for use in construction chemicals, crop protection, fertilizers, industrial solvents, and intermediates. In addition, the company offers active pharmaceutical ingredients, vitamins, and pharmaceutical intermediates, as well as professional services for preparation companies. The company exports its products. The company was incorporated in 1999 and is headquartered in Xinchang, the People's Republic of China. Zhejiang NHU Company Ltd. operates as a subsidiary of NHU Holding Group Co.,Ltd.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Bai Shan Hu
  • Employees11.51K
  • HeadquartersNo.418 Xinchang Dadao West Road, Xinchang, China, 312500, China
  • Websitehttps://www.cnhu.com

Leadership

  • Mr. Bai Shan HuVice-Chairman & President · b. 1967
  • Mr. Guanqun ShiCFO, VP, Secretary & Director · b. 1971
  • Mr. Xue Wen WangVP & Non-Independent Director · b. 1969
  • Ms. Liying ZhangVice President · b. 1977
  • Ms. Xiaobi WangAccounting Supervisor · b. 1982

Financials

Income Statement

Currency: CNY2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue539.10M691.28M950.97M1.13B1.26B1.59B1.75B3.31B2.90B3.45B3.77B3.63B4.24B4.16B3.82B4.70B6.24B8.68B7.66B10.31B14.92B15.93B15.12B21.61B22.25B
Growth (%)-+28.23%+37.57%+19.26%+10.81%+26.45%+9.99%+89.60%-12.55%+18.87%+9.54%-3.77%+16.69%-1.73%-8.20%+22.86%+32.77%+39.27%-11.78%+34.64%+44.63%+6.82%-5.13%+42.95%+2.97%
Cost of Revenue424.89M533.12M746.82M902.32M1.01B1.34B1.39B1.17B1.30B1.66B2.03B2.07B2.64B2.50B2.79B2.58B3.10B4.06B4.07B4.74B8.32B10.21B10.36B12.63B12.31B
Gross Profit114.21M158.17M204.15M231.77M242.42M245.19M358.92M2.14B1.59B1.79B1.75B1.56B1.60B1.66B1.03B2.12B3.13B4.62B3.59B5.57B6.59B5.72B4.75B8.98B9.94B
Gross Margin21.19%22.88%21.47%20.44%19.29%15.43%20.53%64.72%54.98%51.84%46.30%42.98%37.77%39.85%26.96%45.06%50.26%53.25%46.90%54.05%44.19%35.92%31.45%41.55%44.67%
Operating Expense70.60M73.36M101.04M133.40M154.13M127.69M166.64M502.83M317.86M402.66M377.48M402.42M561.69M653.70M561.03M646.13M1.02B993.69M1.03B1.41B1.48B1.41B1.49B2.01B1.96B
Operating Income43.61M84.80M103.11M98.37M88.29M117.49M192.28M1.64B1.28B1.38B1.37B1.16B1.04B1.01B469.38M1.47B2.12B3.63B2.56B4.16B5.12B4.31B3.26B6.97B7.98B
Operating Margin8.09%12.27%10.84%8.67%7.03%7.39%11.00%49.55%44.02%40.15%36.30%31.90%24.51%24.15%12.28%31.30%33.98%41.81%33.46%40.37%34.29%27.07%21.57%32.27%35.85%
EBITDA73.07M155.71M188.82M196.08M191.41M213.67M314.40M1.96B1.42B1.53B1.59B1.40B1.38B1.42B788.84M1.75B2.55B3.95B2.99B5.04B6.32B5.51B4.84B9.26B10.37B
EBITDA Margin13.55%22.52%19.86%17.29%15.23%13.45%17.99%59.28%48.88%44.41%42.09%38.63%32.63%34.02%20.64%37.31%40.94%45.51%39.03%48.85%42.38%34.55%31.99%42.86%46.59%
Net Income42.28M50.85M69.27M72.61M61.18M33.76M77.07M1.37B1.02B1.10B1.16B850.17M882.12M808.04M402.07M1.20B1.70B3.08B2.17B3.56B4.36B3.62B2.70B5.87B6.76B
Net Income Margin7.84%7.36%7.28%6.40%4.87%2.12%4.41%41.48%35.14%31.93%30.85%23.41%20.82%19.40%10.52%25.61%27.34%35.46%28.27%34.55%29.20%22.72%17.89%27.16%30.40%
R&D---------100.93M145.33M160.41M190.45M223.92M201.93M253.41M336.24M457.07M435.04M545.56M782.66M858.95M887.80M1.04B1.10B
R&D as % of Total Revenue---------2.93%3.85%4.42%4.49%5.38%5.28%5.40%5.39%5.26%5.68%5.29%5.25%5.39%5.87%4.79%4.94%
Interest Expense20.51M19.83M22.73M25.85M33.69M56.87M80.15M186.66M55.95M39.28M43.85M47.90M49.78M55.12M38.96M60.40M71.10M92.10M206.47M264.51M348.00M338.68M319.91M290.85M223.18M
Interest Expense % of Total Revenue3.80%2.87%2.39%2.28%2.68%3.58%4.59%5.63%1.93%1.14%1.16%1.32%1.17%1.32%1.02%1.29%1.14%1.06%2.70%2.56%2.33%2.13%2.12%1.35%1.00%

Balance Sheet

Currency: CNY2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets853.45M843.61M1.05B1.60B1.99B2.41B2.53B3.72B4.21B6.15B7.15B7.84B8.56B9.12B9.72B11.41B18.18B21.93B28.72B30.90B34.72B38.27B39.16B42.99B45.61B
Total Liabilities598.73M532.70M694.73M834.49M1.19B1.60B1.67B1.78B1.23B1.31B1.52B1.78B1.99B2.11B2.67B3.32B4.19B5.72B11.66B11.50B12.83B14.61B14.24B13.54B12.65B
Total Equity221.40M276.89M320.95M730.93M755.64M770.67M833.07M1.83B2.78B4.84B5.64B6.05B6.57B7.02B7.05B8.06B13.96B16.17B17.01B19.34B21.83B23.57B24.80B29.32B32.81B
Cash146.29M86.26M158.69M576.85M260.51M289.22M399.93M828.36M661.72M2.29B2.87B2.37B2.66B2.75B2.23B2.01B7.36B2.61B3.43B4.93B5.95B5.34B4.54B7.94B7.97B
Total Debt248.78M275.53M259.74M528.86M469.64M1.03B816.90M1.27B415.94M773.54M530.66M536.42M464.29M779.11M1.58B1.78B2.10B2.28B7.16B6.50B6.56B7.12B8.06B6.49B-
Net Debt102.49M189.27M101.05M-47.98M209.13M741.39M416.97M437.65M-245.78M-1.52B-2.34B-1.83B-2.20B-1.97B-645.47M-231.02M-5.26B-327.16M3.73B1.58B602.17M1.78B3.52B-1.44B-

Cash Flow

Currency: CNY2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-98.04M122.92M123.08M-38.72M82.90M186.00M1.19B1.01B1.30B1.27B985.86M1.34B1.08B972.02M1.19B1.27B3.66B2.10B3.12B5.84B4.36B5.12B7.07B8.80B
Investing Cash Flow--63.91M-116.06M-147.82M-476.25M-247.45M-119.77M-384.19M-458.94M-399.13M-368.14M-845.08M-544.74M-810.94M-1.54B-1.59B-330.97M-8.25B-4.36B-193.63M-3.39B-3.84B-3.88B-3.77B-
Financing Cash Flow--94.18M67.24M428.71M186.13M153.64M49.44M-316.53M-696.54M742.96M-328.69M-724.89M-384.00M-278.93M86.31M88.86M4.42B-308.03M3.03B-1.38B-1.34B-1.27B-2.05B-2.26B-
Capital Expenditure063.88M104.99M104.71M465.92M269.13M125.82M387.27M460.09M418.13M545.71M685.85M755.01M731.46M1.15B1.23B1.02B4.91B4.58B2.35B3.47B4.93B4.45B1.60B1.90B
Free Cash Flow-34.16M17.93M18.37M-504.63M-186.23M60.18M806.02M548.16M886.62M724.36M300.01M580.01M348.27M-174.10M-42.85M255.94M-1.25B-2.47B769.88M2.37B-570.41M673.85M5.47B6.90B
Dividends Paid-22.83M50.45M79.72M67.78M81.88M89.06M452.33M145.62M413.81M404.73M485.30M403.56M405.67M419.43M269.29M715.09M956.59M1.71B1.38B1.50B2.13B1.83B1.66B2.99B
FCF to OCF-34.84%14.59%14.93%1303.37%-224.63%32.36%67.55%54.37%67.95%57.03%30.43%43.45%32.26%-17.91%-3.60%20.13%-34.27%-117.65%24.65%40.51%-13.08%13.16%77.38%78.40%
Dividend Paid to FCF-66.84%281.32%433.91%-13.43%-43.97%147.99%56.12%26.56%46.67%55.87%161.76%69.58%116.48%-240.91%-628.41%279.40%-76.27%-69.31%178.66%63.59%-373.93%272.08%30.39%43.31%

Earnings

Report DateJun 2, 2010Sep 1, 2010Dec 1, 2010Mar 2, 2011Jun 1, 2011Aug 31, 2011Oct 27, 2011Feb 29, 2012Apr 23, 2012Aug 27, 2012Oct 28, 2012Mar 25, 2013May 29, 2013Aug 28, 2013Oct 25, 2013Mar 28, 2014May 28, 2014Aug 26, 2014Oct 29, 2014Feb 26, 2015Apr 27, 2015Aug 2, 2015Oct 29, 2015Feb 27, 2016Apr 27, 2016Aug 15, 2016Oct 27, 2016Feb 27, 2017Apr 21, 2017Aug 22, 2017Oct 25, 2017Feb 27, 2018Apr 24, 2018Aug 22, 2018Oct 21, 2018Feb 26, 2019Apr 28, 2019Aug 22, 2019Oct 23, 2019Feb 27, 2020Apr 27, 2020Aug 27, 2020Oct 28, 2020Mar 30, 2021Apr 28, 2021Aug 19, 2021Oct 28, 2021Feb 27, 2022Apr 27, 2022Aug 23, 2022Oct 25, 2022Feb 24, 2023Apr 20, 2023Aug 29, 2023Oct 26, 2023Dec 31, 2023Apr 29, 2024Aug 23, 2024Oct 23, 2024Dec 31, 2024Apr 28, 2025Aug 27, 2025Oct 29, 2025Dec 31, 2025Apr 28, 2026Aug 19, 2026
EPS Estimate------0.13-0.120.160.080.14--0.130.13-0.320.150.270.130.140.200.050.030.130.070.020.070.060.190.370.250.470.320.470.140.290.260.340.270.350.350.220.380.380.350.270.450.400.380.330.330.250.260.180.320.320.430.420.410.520.460.480.551.19
EPS Actual0.100.110.100.120.110.130.120.080.100.110.090.040.070.080.070.090.080.320.050.090.030.030.040.110.060.190.110.140.120.130.170.440.300.260.150.250.150.250.170.180.290.400.240.200.370.310.310.310.370.330.270.200.210.270.190.220.280.430.580.640.610.590.540.460.580.71
Surprise-------7.69%--16.67%-31.25%12.50%-71.43%---46.15%-30.77%-0.00%-66.67%-66.67%-76.92%-78.57%-80.00%120.00%100.00%46.15%57.14%600.00%71.43%116.67%-10.53%18.92%20.00%-44.68%-53.13%-46.81%7.14%-13.79%-34.62%-47.06%7.41%14.29%-31.43%-9.09%-2.63%-18.42%-11.43%14.81%-17.78%-17.50%-28.95%-39.39%-36.36%8.00%-26.92%22.22%-12.50%34.38%34.88%52.38%48.78%13.46%17.28%-4.17%5.45%-40.34%
Timing------After-hours-After-hoursAfter-hoursAfter-hoursAfter-hours--After-hoursAfter-hours-Pre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-market-Pre-market-Pre-market-After-hoursPre-market--Pre-marketPre-market

Key Statistics & Ratios

Market Cap79.76B
Enterprise Value77.79B
Trailing P/E11.09
Forward P/E11.32
PEG Ratio0.07
Price / Sales3.28
Price / Book2.32
EPS2.34
Book Value11.37
Revenue (TTM)24.28B
Gross Profit (TTM)10.43B
EBITDA10.51B
Profit Margin29.54%
Operating Margin36.37%
Return on Equity21.96%
Return on Assets11.36%
Shares Outstanding3.07B
Shares Float1.45B
Beta0.25
Dividend Yield3.85%
Dividend Rate1.00
Payout Ratio43.68%

Dividends

20261×
0.80May 28, 2026
20253×
0.20Oct 20, 20250.50May 21, 20250.20Jan 22, 2025
20241×
0.45May 29, 2024
20231×
0.50Jun 14, 2023
20221×
0.70May 25, 2022
20211×
0.49May 19, 2021
20201×
0.35Jun 17, 2020
20191×
0.49Jul 12, 2019
20181×
0.29May 30, 2018
20171×
0.25Jun 9, 2017
20161×
0.08Jun 8, 2016
20151×
0.14Jun 18, 2015
20141×
0.14May 16, 2014
20131×
0.14May 9, 2013
20121×
0.16Jun 7, 2012
20111×
0.14May 19, 2011
20101×
0.11May 14, 2010
20091×
0.02May 7, 2009
20082×
0.11Oct 8, 20080.01May 8, 2008
20071×
0.01Jun 5, 2007
20061×
0.01Jun 23, 2006

Stock Splits

  • May 25, 20221.2:1
  • May 19, 20211.2:1
  • May 30, 20181.7:1
  • May 16, 201415:10
  • Oct 18, 201015:10
  • May 14, 201013:10
  • Jun 23, 200620:10
  • Oct 19, 20051.5:1
  • Aug 19, 200513.5:10